Go Deep
PRISM BioLab Co.,LTD
PRISM BioLab Co.,LTD Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 20,994 | -5.6 | 2.64 | 0.00 | 81.72 |
PRISM BioLab Co.,LTD Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 116,466,000.0 | 120,290,000.0 | 132,921,000.0 | 367,597,000.0 |
| Net Profit | -242,358,000.0 | -317,761,000.0 | -285,548,000.0 | -29,762,000.0 |
| EPS | — | — | -7.7 | — |
PRISM BioLab Co.,LTD Revenue & Profit: Last 4 Years
| Line Item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 |
|---|---|---|---|---|
| Revenue | 677,330,000.0 | 305,620,000.0 | 112,926,000.0 | 554,396,000.0 |
| Net Profit | -833,700,000.0 | -1,049,514,000.0 | -526,914,000.0 | 72,962,000.0 |
| EPS | -22.8 | -33.5 | -19.1 | 2.4 |
PRISM BioLab Co.,LTD Balance Sheet
| Line Item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 |
|---|---|---|---|---|
| Total Assets | 3,085,692,000.0 | 4,528,566,000.0 | 1,211,426,000.0 | 1,740,156,000.0 |
| Total Liabilities | 376,863,000.0 | 1,025,665,000.0 | 63,411,000.0 | 65,228,000.0 |
| Total Equity | 2,708,829,000.0 | 3,502,901,000.0 | 1,148,015,000.0 | 1,674,928,000.0 |
Owes vs Owns
PRISM BioLab Co.,LTD owed ¥0.24 for every ¥1 it owned in Jun 2026, up from ¥0.04 in Sep 2022.
| Period | Jun 2026 | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.24× | 0.12× | 0.23× | 0.05× | 0.04× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
PRISM BioLab Co.,LTD Assets & Liabilities Breakdown (JPY millions)
What it owns — Sep 2025
Cash & short-term investments 94.5%Other assets 5.5%
How it's funded — Sep 2025
Payables 3.4%Other liabilities 8.8%Shareholders' equity 87.8%
| Line Item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 2,915.6 | 4,392.0 | 1,133.9 | 1,688.0 |
| Receivables | 0.0 | 0.0 | 0.0 | 21.7 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 0.0 | 0.0 | 0.0 | 0.0 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 170.1 | 136.5 | 77.5 | 30.4 |
| Liabilities & equity | ||||
| Short-term debt | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term debt | 0.0 | 0.0 | 0.0 | 0.0 |
| Payables | 104.7 | 105.7 | 39.8 | 54.8 |
| Other liabilities | 272.2 | 919.9 | 23.6 | 10.5 |
| Shareholders' equity | 2,708.8 | 3,502.9 | 1,148.0 | 1,674.9 |
| Net tangible assets | 2,708.8 | 3,502.9 | 1,148.0 | 1,674.9 |
PRISM BioLab Co.,LTD Cash Flow
| Line Item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 |
|---|---|---|---|---|
| Operating Activities | -1,468,363,000.0 | 150,144,000.0 | -513,811,000.0 | 102,962,000.0 |
| Investing Activities | -69,013,000.0 | -244,187,000.0 | -40,377,000.0 | -7,874,000.0 |
| Financing Activities | 33,588,000.0 | 3,370,055,000.0 | 0.0 | 110,872,000.0 |